<DOC>
	<DOCNO>NCT02030275</DOCNO>
	<brief_summary>The purpose study determine effectiveness RXI-109 reduce recurrence hypertrophic scar formation follow elective revision pre-existing hypertrophic abdominal scar .</brief_summary>
	<brief_title>A Study Evaluate Effectiveness Safety RXI 109 Outcome Scar Revision Surgery Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cicatrix , Hypertrophic</mesh_term>
	<criteria>Adults , 2155 year age general good health Previous partial hysterectomy , Cesarean section abdominoplasty surgery result transverse hypertrophic scar â‰¥ 11 cm length Scar revise must present &gt; 9 month Use tobacco nicotinecontaining product Pregnant lactate Postmenopausal full hysterectomy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Hypertrophic scar</keyword>
	<keyword>Cicatrix</keyword>
	<keyword>Scar prevention</keyword>
	<keyword>Scar revision</keyword>
</DOC>